• shareIcon

Personalised Medicine to be Reality

Latest By Himanshu Sharma , Onlymyhealth editorial team / Dec 11, 2012
Personalised Medicine to be Reality

We may soon have an introduction of DNA mapping for cancer patients and other rare diseases, which will make personalised medicine a reality. A report of Life Sciences Strategy revealed that United Kingdom Government generated over £1billion

Personalised Medicine to be Reality

Personalised medicine that exists in conceptual terms could a reality soon. According to a report of Life Sciences Strategy, United Kingdom Government has generated more than £1billion on industry and private sector investment within 12 months for DNA mapping.

Sir John Bell, professor of medical sciences at Oxford University, stated that the price of genome sequencing has fallen considerably, by 100,000-fold in 10 years. £100 a genome will happen in the very near future.

 

[Read: Best Treatment for Cancer]


The Prime Minister of United Kingdom, Mr. David Cameron, will be announcing plans to transform cancer treatment in with new proposals that will see the introduction of DNA mapping for cancer patients and rare diseases.

The move designed to combat cancer and rare diseases will make United Kingdom the first country to introduce hi-tech DNA mapping within a mainstream healthcare system.

 

Read more Health News

 

Disclaimer

All possible measures have been taken to ensure accuracy, reliability, timeliness and authenticity of the information; however Onlymyhealth.com does not take any liability for the same. Using any information provided by the website is solely at the viewers’ discretion. In case of any medical exigencies/ persistent health issues, we advise you to seek a qualified medical practitioner before putting to use any advice/tips given by our team or any third party in form of answers/comments on the above mentioned website.

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK